HALOPERIDOL, 5mg/ml, 1ml, amp.

STD DINJHALP5A-

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
2.3 - Medicines for other common symptoms in palliative care
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
24.1 - Medicines for psychotic disorders
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
N05AD01
Anatomical Therapeutic Chemical Classification according to WHOCC
Substance listed as Narcotic Drug or Psychotropic Substance, and as precursors. Other substances may be subject to restrictions according to national regulations. These substances require an import permit from the country of destination when ordering.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

HALOPERIDOL

Therapeutic Action

Antipsychotic (neuroleptic)

Indications

Acute confusional state (delirium) and acute alcohol intoxication

Agitation or aggressive behaviour in patients with acute or chronic psychosis, in association with promethazine

Instructions for use

Must be given as IM injection.

It is recommended to order biperiden (or trihexyphenidyl) together with haloperidol, to be given in the event of extrapyramidal disorders.

In some countries, haloperidol is on the list of narcotics: follow national regulations (Cf Introduction: Narcotic and psychotropic medicines under international control)

Precautions for Use

Do not administer in patients with cardiac disorders, dementia, Parkinson's disease and history of neuroleptic malignant syndrome.

Administer with caution and carefully monitor use in elderly patients and patients with hypokalaemia, hypotension, hyperthyroidism, renal or hepatic impairment, history of seizures.

Do not confuse with haloperidol decanoate (long-acting) used in the treatment of chronic psychotic disorders after stabilisation with oral treatment.

Storage

Below 25ºC - Protect from sunlight